A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis
Clinical trial NCT06284954 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06284954
- Sponsor
- argenx
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-20
- Primary completion
- 2026-11-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.